vs

Side-by-side financial comparison of Emerson Electric (EMR) and Vistra Corp. (VST). Click either name above to swap in a different company.

Vistra Corp. is the larger business by last-quarter revenue ($4.8B vs $4.3B, roughly 1.1× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 4.8%, a 9.1% gap on every dollar of revenue. On growth, Vistra Corp. posted the faster year-over-year revenue change (31.2% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $596.0M). Over the past eight quarters, Vistra Corp.'s revenue compounded faster (23.3% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Vistra may refer to either of two companies:Vistra, a corporate services company based in Hong Kong Vistra Corp, an energy company based in Texas

EMR vs VST — Head-to-Head

Bigger by revenue
VST
VST
1.1× larger
VST
$4.8B
$4.3B
EMR
Growing faster (revenue YoY)
VST
VST
+27.1% gap
VST
31.2%
4.1%
EMR
Higher net margin
EMR
EMR
9.1% more per $
EMR
13.9%
4.8%
VST
More free cash flow
EMR
EMR
$6.0M more FCF
EMR
$602.0M
$596.0M
VST
Faster 2-yr revenue CAGR
VST
VST
Annualised
VST
23.3%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMR
EMR
VST
VST
Revenue
$4.3B
$4.8B
Net Profit
$605.0M
$233.0M
Gross Margin
53.2%
Operating Margin
17.8%
9.9%
Net Margin
13.9%
4.8%
Revenue YoY
4.1%
31.2%
Net Profit YoY
3.4%
-47.2%
EPS (diluted)
$1.07
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
VST
VST
Q4 25
$4.3B
$4.8B
Q3 25
$4.9B
$4.8B
Q2 25
$4.6B
$3.8B
Q1 25
$4.4B
$4.3B
Q4 24
$4.2B
$3.7B
Q3 24
$4.6B
$4.3B
Q2 24
$4.4B
$3.6B
Q1 24
$4.4B
$3.2B
Net Profit
EMR
EMR
VST
VST
Q4 25
$605.0M
$233.0M
Q3 25
$637.0M
$652.0M
Q2 25
$586.0M
$327.0M
Q1 25
$485.0M
$-268.0M
Q4 24
$585.0M
$441.0M
Q3 24
$996.0M
$1.9B
Q2 24
$329.0M
$365.0M
Q1 24
$501.0M
$-35.0M
Gross Margin
EMR
EMR
VST
VST
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
EMR
EMR
VST
VST
Q4 25
17.8%
9.9%
Q3 25
16.4%
21.7%
Q2 25
16.1%
13.7%
Q1 25
14.2%
-2.8%
Q4 24
18.6%
16.4%
Q3 24
14.7%
59.6%
Q2 24
10.4%
22.5%
Q1 24
16.2%
2.7%
Net Margin
EMR
EMR
VST
VST
Q4 25
13.9%
4.8%
Q3 25
13.1%
13.6%
Q2 25
12.9%
8.7%
Q1 25
10.9%
-6.3%
Q4 24
14.0%
12.0%
Q3 24
21.6%
43.5%
Q2 24
7.5%
10.1%
Q1 24
11.4%
-1.1%
EPS (diluted)
EMR
EMR
VST
VST
Q4 25
$1.07
$0.55
Q3 25
$1.12
$1.75
Q2 25
$1.04
$0.81
Q1 25
$0.86
$-0.93
Q4 24
$1.02
$1.09
Q3 24
$1.74
$5.25
Q2 24
$0.57
$0.90
Q1 24
$0.87
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
VST
VST
Cash + ST InvestmentsLiquidity on hand
$785.0M
Total DebtLower is stronger
$7.6B
$15.8B
Stockholders' EquityBook value
$20.3B
$5.1B
Total Assets
$41.9B
$41.5B
Debt / EquityLower = less leverage
0.37×
3.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
VST
VST
Q4 25
$785.0M
Q3 25
$602.0M
Q2 25
$458.0M
Q1 25
$561.0M
Q4 24
$1.2B
Q3 24
$905.0M
Q2 24
$1.6B
Q1 24
$1.1B
Total Debt
EMR
EMR
VST
VST
Q4 25
$7.6B
$15.8B
Q3 25
$8.9B
$15.8B
Q2 25
$8.3B
$15.5B
Q1 25
$8.2B
$15.4B
Q4 24
$6.6B
$15.4B
Q3 24
$7.7B
$13.9B
Q2 24
$7.1B
$13.9B
Q1 24
$7.6B
$14.7B
Stockholders' Equity
EMR
EMR
VST
VST
Q4 25
$20.3B
$5.1B
Q3 25
$20.3B
$5.2B
Q2 25
$19.9B
$4.8B
Q1 25
$19.2B
$4.8B
Q4 24
$20.5B
$5.6B
Q3 24
$21.6B
$5.4B
Q2 24
$20.8B
$5.6B
Q1 24
$20.9B
$5.7B
Total Assets
EMR
EMR
VST
VST
Q4 25
$41.9B
$41.5B
Q3 25
$42.0B
$38.0B
Q2 25
$42.5B
$38.1B
Q1 25
$42.0B
$38.2B
Q4 24
$42.6B
$37.8B
Q3 24
$44.2B
$37.9B
Q2 24
$45.6B
$39.1B
Q1 24
$46.4B
$38.2B
Debt / Equity
EMR
EMR
VST
VST
Q4 25
0.37×
3.11×
Q3 25
0.44×
3.02×
Q2 25
0.42×
3.22×
Q1 25
0.42×
3.20×
Q4 24
0.32×
2.77×
Q3 24
0.36×
2.56×
Q2 24
0.34×
2.49×
Q1 24
0.36×
2.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
VST
VST
Operating Cash FlowLast quarter
$699.0M
$1.4B
Free Cash FlowOCF − Capex
$602.0M
$596.0M
FCF MarginFCF / Revenue
13.9%
12.4%
Capex IntensityCapex / Revenue
2.2%
17.4%
Cash ConversionOCF / Net Profit
1.16×
6.15×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
VST
VST
Q4 25
$699.0M
$1.4B
Q3 25
$3.1B
$1.5B
Q2 25
$1.1B
$572.0M
Q1 25
$241.0M
$599.0M
Q4 24
$777.0M
$1.4B
Q3 24
$3.3B
$1.7B
Q2 24
$1.1B
$1.2B
Q1 24
$743.0M
$312.0M
Free Cash Flow
EMR
EMR
VST
VST
Q4 25
$602.0M
$596.0M
Q3 25
$2.7B
$1.0B
Q2 25
$977.0M
$-118.0M
Q1 25
$154.0M
$-169.0M
Q4 24
$694.0M
$923.0M
Q3 24
$2.9B
$1.0B
Q2 24
$998.0M
$698.0M
Q1 24
$661.0M
$-153.0M
FCF Margin
EMR
EMR
VST
VST
Q4 25
13.9%
12.4%
Q3 25
54.9%
21.1%
Q2 25
21.5%
-3.1%
Q1 25
3.5%
-4.0%
Q4 24
16.6%
25.2%
Q3 24
63.1%
23.4%
Q2 24
22.8%
19.4%
Q1 24
15.1%
-4.8%
Capex Intensity
EMR
EMR
VST
VST
Q4 25
2.2%
17.4%
Q3 25
8.9%
9.6%
Q2 25
2.0%
18.4%
Q1 25
2.0%
18.1%
Q4 24
2.0%
11.7%
Q3 24
9.1%
15.8%
Q2 24
2.1%
13.8%
Q1 24
1.9%
14.7%
Cash Conversion
EMR
EMR
VST
VST
Q4 25
1.16×
6.15×
Q3 25
4.86×
2.25×
Q2 25
1.83×
1.75×
Q1 25
0.50×
Q4 24
1.33×
3.07×
Q3 24
3.35×
0.90×
Q2 24
3.31×
3.28×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

VST
VST

Retail Energy Charge In ERCOT$2.1B43%
Retail Energy Charge In Northeast Midwest$1.2B24%
East Segment$1.1B24%
Hedging Revenue Realized$170.0M4%
Revenue From Other Wholesale Contracts$116.0M2%
Transferable Production Tax Credit Revenues$78.0M2%
West Segment$77.0M2%
Intersegment Sales$25.0M1%

Related Comparisons